Brain Health & Cognitive Optimization: A Precision Medicine Guide

Most patients think of cognitive decline as something that happens in the late 60s or 70s — a gradual fogging that arrives decades after the body starts ageing. The data tells a different story. Processing speed, working memory, and the speed of synaptic transmission all begin declining measurably in the early 40s. By the time symptoms are noticeable, the underlying biological processes have been running for 15 to 20 years.

This matters because the interventions that work best — optimising neurosteroids, supporting cerebral circulation, correcting iodine and thyroid function — work best early. They slow the trajectory. They do not reverse advanced damage.

What follows is my clinical framework for approaching cognitive health before symptoms appear.

Why Cognitive Decline Starts at 40

Three converging processes drive early cognitive ageing, and they rarely occur in isolation.

Hormone decline. Pregnenolone, DHEA, testosterone, and thyroid hormones all fall steadily after the mid-30s. These are not peripheral hormones — they are directly synthesised in the brain and act on neuronal membranes, mitochondria, and synaptic receptor density. When they drop, the brain’s capacity for energy production, plasticity, and signal fidelity falls with them.

Reduced cerebral blood flow. The brain consumes roughly 20% of the body’s oxygen at rest despite representing only 2% of body weight. It is exquisitely sensitive to reductions in perfusion. Arterial stiffening, which begins accumulating from the mid-30s, progressively reduces the microcirculation that feeds neurons. Neurons cannot be regenerated — any ischaemic damage is permanent. Protecting perfusion is therefore a primary intervention, not an afterthought.

Micronutrient depletion. Iodine deficiency is the most common preventable cause of cognitive impairment worldwide. In Spain, subclinical deficiency is more prevalent than most patients expect, particularly in those who avoid seafood or use non-iodised salt. Iodine is essential for thyroid hormone synthesis, and thyroid hormones regulate virtually every aspect of neuronal metabolism — energy production, myelination, synaptic density, and the speed of signal transmission.

The practical implication: if you are 40 and your cognitive function feels fine today, that is expected. The biological changes are subclinical at this stage. The question is where you will be at 55 or 65 — and that trajectory is largely set by what happens in the next decade.

Pregnenolone: The Master Precursor

Pregnenolone is synthesised from cholesterol, primarily in the adrenal glands and locally within the brain itself. It is the upstream precursor for every steroid hormone: DHEA, cortisol, progesterone, testosterone, and oestradiol all derive from it. Because of this position in the steroidogenic cascade, a fall in pregnenolone has downstream consequences across the entire hormonal architecture.

From a cognitive standpoint, three mechanisms are most clinically relevant:

• Memory consolidation. Pregnenolone enhances NMDA receptor function in the hippocampus — the brain structure most directly responsible for converting short-term experience into long-term memory. Low pregnenolone impairs this process measurably, producing the characteristic difficulty with recent memory that patients describe as “not being able to hold onto things.”
• Sleep architecture. Pregnenolone collaborates with tryptophan in the synthesis of melatonin. When pregnenolone is low, melatonin production becomes irregular, sleep depth decreases, and the overnight memory consolidation and waste clearance (via the glymphatic system) that healthy sleep provides is impaired. This creates a compounding loop: poor sleep accelerates neurodegeneration, which further reduces pregnenolone synthesis.
• Mood and stress resilience. Pregnenolone modulates GABA and dopamine neurotransmission. Low levels are consistently associated with reduced stress tolerance, low motivation, and subclinical depression — none of which are cognitive symptoms in the traditional sense, but all of which significantly impair cognitive performance in daily life.

Pregnenolone levels decline with age starting in the mid-30s, and this decline accelerates under chronic stress (because cortisol demand pulls precursors away from other downstream hormones). Measuring serum pregnenolone is a straightforward blood test. In patients with confirmed low levels, physician-supervised supplementation or DHEA optimisation can restore the downstream cascade.

Clinical note: Supplementing pregnenolone without first testing levels is guesswork. The correct dose varies significantly between patients — what restores normal function in one patient may suppress endogenous synthesis in another. Testing first, then titrating, is the appropriate protocol.

Vinpocetine: Protecting Cerebral Circulation

Vinpocetine is a synthetic derivative of vincamine, an alkaloid extracted from the periwinkle plant (Vinca minor). It has been used clinically in Europe for decades, primarily for cerebrovascular conditions and cognitive support. Its mechanism is well-characterised.

Vinpocetine increases cerebral blood flow by relaxing vascular smooth muscle and reducing platelet aggregation. Studies have measured increases in cerebral perfusion of up to 7% — modest in absolute terms, but clinically significant given the brain’s sensitivity to even small perfusion changes. It also inhibits phosphodiesterase type 1 (PDE1), which elevates cyclic GMP levels in smooth muscle cells and sustains vasodilation over time.

The neuroprotective effects work through a second pathway: mitochondrial protection. When neurons are over-stimulated — as occurs in ischaemia or chronic metabolic stress — excitotoxicity depletes mitochondrial energy reserves and triggers cell death. Vinpocetine reduces excitotoxic damage by stabilising mitochondrial membrane potential and limiting calcium influx. Enhanced mitochondrial function means neurons can sustain higher activity levels without accumulating damage.

The clinical applications most relevant to anti-ageing medicine are:

• Supporting cerebral microcirculation in patients with early arterial stiffening
• Adjunctive support following transient ischaemic events
• Improving working memory and processing speed in patients with confirmed cerebrovascular insufficiency

Vinpocetine is generally well-tolerated but should not be combined with anticoagulants without medical supervision. As with all interventions in this area, the benefit depends on the underlying deficit — it works best in patients where poor perfusion is a documented part of the problem, not as a universal cognitive booster.

Iodine, Thyroid, and the Brain Connection

Iodine is a trace mineral with a single dominant function: it is the essential raw material for thyroid hormone synthesis. The thyroid cannot produce T3 or T4 without adequate iodine. And without adequate T3, the brain cannot function at its optimal capacity.

Thyroid hormones regulate neuronal metabolism at a fundamental level. They control the rate of ATP production in neurons, the speed of myelin synthesis (which determines signal transmission speed along axons), the density of synaptic receptors, and the expression of BDNF — the growth factor most directly responsible for neuronal survival and the formation of new connections.

When iodine is insufficient, the thyroid compensates by enlarging (goitre) and working harder, but eventually T3 output falls. The cognitive consequences are not subtle: difficulty concentrating, slowed processing, reduced verbal fluency, memory gaps, and fatigue that does not resolve with sleep. These symptoms are frequently attributed to ageing, stress, or depression — when the root cause is a correctable nutritional deficit.

Iodine-rich foods that can meaningfully contribute to daily intake:

• Seaweed (nori, kombu, wakame) — highest natural source; 1 sheet of nori provides approximately 25–45 mcg
• Seafood — cod, shrimp, tuna, and sardines all provide 30–100 mcg per serving
• Eggs — approximately 25 mcg per egg, concentrated in the yolk
• Dairy (milk, yoghurt, cheese) — 50–100 mcg per serving, depending on farming practices
• Beets and dark leafy greens (chard, spinach) — modest iodine content but contribute alongside other micronutrients

The recommended daily intake for adults is 150 mcg. Pregnant women require 220–250 mcg. Importantly, more is not better — excess iodine can paradoxically suppress thyroid function (the Wolff-Chaikoff effect). Supplementation without testing is therefore not appropriate. A urinary iodine concentration test or full thyroid panel (TSH, free T3, free T4) should precede any targeted supplementation.

In Spain, tap water in some regions contains fluoride, which competes with iodine at thyroid receptor sites. This increases the effective iodine requirement for patients drinking unfiltered municipal water — an underappreciated factor in subclinical hypothyroidism.

Testing Your Cognitive Biomarkers

The most common mistake in cognitive optimisation is treating symptoms without measuring the underlying biology. Fatigue, brain fog, and poor memory can each have five or six distinct biochemical causes — and the intervention that works for one cause actively worsens another. Testing first eliminates guesswork.

The core panel I use for cognitive assessment:

Biomarker	What It Reveals	Target (general guidance)
Pregnenolone (serum)	Neurosteroid reserve; upstream hormone capacity	Age-appropriate reference range
DHEA-S	Adrenal reserve; downstream from pregnenolone	Age-appropriate; often low by 50s
Free testosterone	Neuroprotection, motivation, BDNF support	Upper-normal quartile for age
TSH + free T3 + free T4	Thyroid function; metabolic rate in neurons	TSH 1–2 mIU/L; T3 upper third of range
Urinary iodine	Iodine adequacy; thyroid substrate	100–199 mcg/L (sufficient); >300 excess
Homocysteine	Methylation efficiency; neurotoxicity marker	<8 mcmol/L
Fasting insulin	Insulin resistance; glucose delivery to neurons	<8 mIU/L fasting
BDNF (plasma)	Neuroplasticity; new synapse formation capacity	Higher is better; exercise is primary driver

None of these markers is definitive in isolation. The value is in the pattern. A patient with low pregnenolone, low free T3, and elevated homocysteine has a very different biological picture — and requires a very different protocol — than one with optimal hormones but low BDNF and insulin resistance.

This is what precision medicine means in practice: not applying a standard supplement protocol to everyone who reports brain fog, but identifying which specific mechanisms are underperforming in that individual and addressing them directly.

If you already have recent blood work, you can get a quick read on where you stand using Optimal Blood — it compares your values to longevity-optimized ranges rather than standard lab reference intervals.

Our Lucidity Cognitive Optimisation Programme includes this full biomarker panel, a comprehensive review of cognitive symptoms and risk factors, and a personalised protocol based on your specific results. For patients who want to understand exactly where their brain is losing ground — and what can be done about it — this is the appropriate starting point.

References: Baulieu EE — Neurosteroids, a function of the brain (1997) · Abdel-Nour T et al — Vinpocetine: PDE1 inhibition and cerebral circulation (2002) · WHO — Iodine deficiency and cognitive impairment (2007) · Squire LR — Memory and the hippocampus: a synthesis (1992) · Lezoualc’h F et al — Thyroid hormones and brain development (2000) · BDNF and insulin resistance (PMID 38723899)